RemSleep Holdings (RMSL) Interest Coverage Ratio (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.93% |
| Sep 30, 2025 | -1,801.27% |
| Jun 30, 2025 | 46.36% |
| Mar 31, 2025 | 82.79% |
| Dec 31, 2024 | -231.58% |
| Sep 30, 2024 | 66.56% |
| Jun 30, 2024 | -103.05% |
| Jun 30, 2023 | -192.91% |
| Mar 31, 2023 | 42.60% |
| Dec 31, 2022 | -34.47% |
| Sep 30, 2022 | -724.40% |
| Jun 30, 2022 | -638.53% |
| Mar 31, 2022 | -111.64% |
| Dec 31, 2021 | -23.71% |
| Sep 30, 2021 | 39.85% |
| Jun 30, 2021 | 0.13% |
| Mar 31, 2021 | 58.09% |
| Dec 31, 2020 | -240.09% |
| Sep 30, 2020 | 50.32% |
| Jun 30, 2020 | -61.73% |
| Mar 31, 2020 | 21.76% |
| Dec 31, 2019 | 27.23% |
| Sep 30, 2019 | 97.10% |
| Jun 30, 2019 | -529.63% |
| Mar 31, 2019 | -104.17% |
| Dec 31, 2018 | 200.07% |
| Sep 30, 2018 | 76.85% |
| Jun 30, 2018 | -109.90% |
| Mar 31, 2018 | -74.09% |
| Dec 31, 2017 | 22.36% |
| Sep 30, 2017 | 24.32% |
| Dec 31, 2013 | -113.20% |
| Sep 30, 2013 | -81.36% |